z-logo
open-access-imgOpen Access
Biological action of inosine analogs in Leishmania and Trypanosoma spp
Author(s) -
J. Joseph Marr,
Randolph L. Berens,
Naomi K. Cohn,
Donald J. Nelson,
Robert S. Klein
Publication year - 1984
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.25.2.292
Subject(s) - inosine , antiprotozoal , leishmania donovani , leishmania , trypanosoma cruzi , biology , trypanosoma , kinetoplastida , protozoa , purine analogue , leishmaniasis , pharmacology , microbiology and biotechnology , virology , biochemistry , purine , protozoal disease , adenosine , in vitro , immunology , parasite hosting , enzyme , malaria , visceral leishmaniasis , world wide web , computer science
Previous investigations have suggested that inosine analogs would be good models for the development of chemotherapeutic agents active against pathogenic hemoflagellates. We have systematically modified the five-membered heterocyclic ring of six inosine analogs and tested them for their antiprotozoal activities and toxicity to a mammalian cell line. All six analogs were very active against the three protozoan pathogens Leishmania donovani, Trypanosoma cruzi, and Trypanosoma gambiense. Two of the six, 9-deazainosine and allopurinol ribonucleoside, had very little toxicity for mouse L cells and offer promise as potential chemotherapeutic agents.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom